期刊文献+

氟利昂替代后吸入气雾剂(MDIs)的研究要求和进展 Ⅰ.欧美抛射剂替代的MDIs的研发和质量控制 被引量:10

Chlorofluorocarbons Transition of Metered Dose Inhalers (MDIs). Ⅰ. Development and Quality Control of Alternative Propellant MDIs in the USA and Europe
下载PDF
导出
摘要 分析了欧美国家近20年吸入气雾剂(MDIs)中抛射剂替代的技术、法规、监管的经验和教训;总结了抛射剂替代后MDIs临床前研究的重点考察项目和成品质控的具体要求;介绍了国外MDIs的分类和单个品种与整个类别的淘汰策略。 This paper reviews the technology, quality control and regulations for altemative propellant MDIs in the USA and Europe in the past 20 years and summarizes the main pharmaceutical tests during pre-clinical development and specifications for HFA-MDIs products. The MDIs medication categories, strategies and current status for phase-out of CFC-MDIs abroad are introduced.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2009年第7期543-548,共6页 Chinese Journal of Pharmaceuticals
关键词 吸入气雾剂 抛射剂替代 质控技术 淘汰策略 metered dose inhalers propellant replacement quality control phase-out strategy
  • 相关文献

参考文献4

二级参考文献53

  • 1张英丰,周莉玲.青藤碱贴剂透皮吸收数据的灰色GM(1,1)拟合及与相关模型的比较研究[J].中成药,2007,29(1):48-51. 被引量:1
  • 2Shah VP. IV-IVC for topically applied preparations a critical evaluation [J]. Eur J Pharm Biopharm, 2005, 60 (2) : 309-314.
  • 3Balan G, Timmins P, Greene DS, et al. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers [J]. JPharm Sci, 2001, 90(8): 1176-1185.
  • 4Parojcic J, lbrid S, Djuric Z, et al. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation [J]. EurJPharm Sci, 2007, 30 (3-4): 264-272.
  • 5Sugawara M, Kadomura S, He X, et al. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations [J]. EurJPharm Sci, 2005, 26 (1) : 1-8.
  • 6Dressman JB, Reppas C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs [J]. Eur J Pharm Sci, 2000, 11 (Suppl 2) : S73-S80.
  • 7Fujioka Y, Kadono K, Fujie Y, et al. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for invitro dissolution study [J] . J Controlled Release, 2007, 119 (2) : 222-228.
  • 8Lin SY, Hou S J, Hsu TH, et al. Comparisons of different animal skins with human skin in drug percutaneous penetration studies [J]. Methods Find Exp Clin Pharmacol, 1992, 14 (8) : 645-654.
  • 9Netzlaff F, Lehr CM, Wertz PW, et al. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport [J]. Eur J Pharm. Biopharm, 2005, 60 (2): 167-178.
  • 10Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability [J]. J Pharm Pharmacol, 1992, 44 (8) : 640-645.

共引文献16

同被引文献89

  • 1张慧燕.关于完善中药气雾剂质量标准的建议[J].中国药品标准,2005,6(1):55-56. 被引量:2
  • 2高杨,金玉燕,张钧寿.压力定量吸入剂的质量评价与影响因素[J].药学进展,2005,29(8):364-370. 被引量:2
  • 3陈桂良,侯惠民.以氯氟烃(CFC)和氢氟烷(HFA)为抛射剂的沙丁胺醇气雾剂的特性比较[J].药物分析杂志,2006,26(1):144-147. 被引量:9
  • 4Tansey IP.Changing to CFC-free inhalers:the technical and clinical challenges[J].Pharm J,1997,259 (6971):896-898.
  • 5Thiel CG.From Susie's Question to CFC Free:An inventor's perspective on forty years of MDI development and regulation[J].Respiratory Drug Delivery V,1996,(1):115-124.
  • 6Dalziel SM,Creazzo JA.A propellant and particle perspective on pulmonary drug delivery[J].Spray Tech Marketing,2003,(6):20-24.
  • 7Vervaet C,Byron PR.Drug-surfactant-propellant interactions in HFA-formulations[J].Inter J Pharm,1999,186(1):13-30.
  • 8Dietlen S,Hieronymus H,Plewinsky B,et al.Explosion behaviour of the 'non-flammable' CFC substitute 1,1,1,2-tetra fluoroethane (R134a)[J].Chem Eng Process,1995,34 (3):141-149.
  • 9Polli GP,Grim WM,Bather FA,et al.Influence of formulation on aerosol panicle size[J].J Pharm Sci,1969,58 (4):484-486.
  • 10McDonald KJ,Martin GP.Transition to CFC-free metered dose inhalers--into the new millennium[J].Inter J Pharm,2000,201 (1):89-107.

引证文献10

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部